** Island Pharmaceuticals ILA.AX jumps as much as 13.8% to A$0.165, highest since June 17
** Drug company signs asset purchase agreement to acquire Galidesivir antiviral program from BioCryst Pharmaceuticals Inc BCRX.O
** Galidesivir is a clinical-stage antiviral molecule with broad spectrum of activity in more than 20 RNA viruses, including high-priority threats such as Ebola and Marburg
** YTD, ILA down 11.8%
(Reporting by Sherin Sunny in Bengaluru)
((Sherin.Sunny@thomsonreuters.com;))